View in EDS HTML Full Text PDF Full Text

Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress.

Saved in:
Bibliographic Details
Title: Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress.
Authors: Jiang, Xinghao1 (AUTHOR), Wu, Qing1 (AUTHOR), Opoku, Yeboah Kwaku1,2 (AUTHOR), Zou, Yimeng1 (AUTHOR), Wang, Dan1 (AUTHOR), Hu, Changhui1 (AUTHOR), Ren, Guiping1,3 (AUTHOR) renguiping@126.com
Source: Basic & Clinical Pharmacology & Toxicology. Dec2022, Vol. 131 Issue 6, p474-486. 13p.
Database: Environment Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: eih
DbLabel: Environment Complete
An: 160177988
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Jiang%2C+Xinghao%22">Jiang, Xinghao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Qing%22">Wu, Qing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Opoku%2C+Yeboah+Kwaku%22">Opoku, Yeboah Kwaku</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zou%2C+Yimeng%22">Zou, Yimeng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Dan%22">Wang, Dan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Changhui%22">Hu, Changhui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ren%2C+Guiping%22">Ren, Guiping</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<i> renguiping@126.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Basic+%26+Clinical+Pharmacology+%26+Toxicology%22">Basic & Clinical Pharmacology & Toxicology</searchLink>. Dec2022, Vol. 131 Issue 6, p474-486. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=eih&AN=160177988
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bcpt.13793
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 474
    Titles:
      – TitleFull: Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jiang, Xinghao
      – PersonEntity:
          Name:
            NameFull: Wu, Qing
      – PersonEntity:
          Name:
            NameFull: Opoku, Yeboah Kwaku
      – PersonEntity:
          Name:
            NameFull: Zou, Yimeng
      – PersonEntity:
          Name:
            NameFull: Wang, Dan
      – PersonEntity:
          Name:
            NameFull: Hu, Changhui
      – PersonEntity:
          Name:
            NameFull: Ren, Guiping
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 17427835
          Numbering:
            – Type: volume
              Value: 131
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Basic & Clinical Pharmacology & Toxicology
              Type: main
ResultId 1